ACOG 8-K: Board change

Filed with the SEC on · accession 0001213900-26-118958

ACOG filed a 8-K (current report) with the SEC on Nov 12, 2026. Alpha Cognition Inc. appointed Caren Deardorf as a director effective November 11, 2026, and reconstituted its board committees. The stock moved +1.0% by the first close after the filing.

Summary of the filing

Alpha Cognition Inc. appointed Caren Deardorf as a director effective November 11, 2026, and reconstituted its board committees. She received an initial equity grant of 755 restricted stock units and 1,020 stock options at an exercise price of $8.62 per share.

Key details

Restricted stock units granted to Caren Deardorf$755
Stock options granted to Caren Deardorf$1K
Exercise price per share of stock options granted to Caren Deardorf$9
RegistrantAlpha Cognition Inc.
Current employer of appointed director caren deardorfNeutrolis Inc.
Former employer of appointed director caren deardorfEditas Medicine
Former employer of appointed director caren deardorfMagenta Therapeutics
Former employer of appointed director caren deardorfOhana Biosciences
Former board affiliation of appointed director caren deardorfCrinetics Pharmaceuticals
Former board affiliation of appointed director caren deardorfNeuroSense Therapeutics
DirectorCaren Deardorf
Chief executive officerMichael McFadden

How ACOG stock reacted

Close before

$8.62

Nov 11, 2026

First close after

+1.04%

$8.71

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for ACOG, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ACOG?

Click here

Frequently asked questions

What did ACOG file with the SEC on Nov 12, 2026?

ACOG filed a 8-K (Board change). Alpha Cognition Inc. appointed Caren Deardorf as a director effective November 11, 2026, and reconstituted its board committees. She received an initial equity grant of 755 restricted stock units and 1,020 stock options at an exercise price of $8.62 per share.

What does a board change mean for ACOG stock?

Not always. A planned retirement with a successor is usually calm; a sudden departure “effective immediately”, especially of a CFO or near results, often worries investors.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

How did ACOG stock react to this filing?

ACOG closed at $8.62 before the filing and $8.71 on Nov 12, 2026 (+1.04%).

Other ACOG SEC filings

Get alerts when ACOG files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days